Recordati

REC

IT0003828271

Pharmaceuticals

Real-time Borsa Italiana Other stock markets 10:02:57 2026-02-18 am EST			5-day change	1st Jan Change
48.30 ^EUR	+2.03%		+1.73%	-0.49%

08:58am	Italy's Recordati is looking at possible M&A deals, CEO says	RE
07:09am	Milan Stock Exchange Strengthens Ahead of Wall Street Open, Mediobanca and Erg Surge	RE

Recordati Acquires 13,050 Own Shares for Approximately EUR570,000

Published on 12/23/2025 at 01:04 pm EST

Alliance News - Translated by Marketscreener - See original

RECORDATI

+2.03%

(Alliance News) - Recordati Spa announced on Tuesday that it acquired 13,050 of its own ordinary shares between December 17 and 19.

The shares were purchased at an average unit price of EUR48.3650, for a total consideration of EUR565,913.25.

Following these transactions, the company now holds a total of 4.7 million treasury shares, representing approximately 2.3% of its share capital.

Recordati's stock closed up 0.5% at EUR48.68 per share.

By Antonio Di Giorgio, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Latest news about Recordati

08:58am	Italy's Recordati is looking at possible M&A deals, CEO says	RE
07:09am	Milan Stock Exchange Strengthens Ahead of Wall Street Open, Mediobanca and Erg Surge	RE
05:57am	MIB Rallies Again, Driven by MPS and Mediobanca	AN
03:57am	Mib and European Stocks Edge Higher; Mediobanca Outshines All	AN
12:02am	Italy - Factors to watch on February 18	RE
Feb. 17	Italy's Recordati targets 2026 core profit increase	RE
Feb. 17	Recordati Industria Chimica E Farmaceutica S.P.A. Provides Earnings Guidance for the Year 2026; Re-Affirms Earnings Guidance for the Year 2027	CI
Feb. 17	Recordati Posts Strong Results with Rising Profits and Revenues	AN
Feb. 17	Recordati FY EBITDA EUR 991.1 mln	RE
Feb. 17	Mib Recovers Below 45,600; Inwit and Italgas Lead the Way	AN
Feb. 17	Bearish Outlook for the Second Day of the Week	AN
Feb. 17	Italy - Factors to watch on February 17	RE
Feb. 16	Recordati Acquires 64,038 Treasury Shares for Over EUR3 Million	AN
Feb. 16	Galderma Group AG Announces the Appointment of Luigi La Corte as Chief Financial Officer, Effective May 1, 2026	CI
Feb. 16	Dermatology Company Galderma Group Names New CFO	MT

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (64.4%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (35.6%). Net sales are distributed geographically as follows: Italy (14.3%), Europe (56.1%), America (20.4%), Asia and Oceania (6.7%) and Africa (2.5%).

Employees

4,539

Sector

Pharmaceuticals

Calendar

Feb. 18 - Q4 2025 Earnings Release (Projected)

More about the company